Blurred Vision, Hidden Danger: Drug-Induced Glaucoma Following Olanzapine Therapy

Blurred Vision, Hidden Danger: Drug-Induced Glaucoma Following Olanzapine Therapy

Saved in:

Bibliographic Details
Main Author:	Shatavisa Mukherjee
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-04-01
Series:	TNOA Journal of Ophthalmic Science and Research
Online Access:	https://journals.lww.com/10.4103/tjosr.tjosr_50_25
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Olanzapine-induced neutropenia
by: Kirti Malhotra, et al.
Published: (2015-06-01)

Case report: Endolymphatic sac tumor with blurred vision
by: Ke Yuan, et al.
Published: (2025-01-01)

Vision is adapted to the natural level of blur present in the retinal image.
by: Lucie Sawides, et al.
Published: (2011-01-01)

Olanzapine-induced reversible skin eruption
by: Rohit P. Deshmukh
Published: (2023-05-01)

Olanzapine-induced Pancytopenia: Case Report
by: A Prajnashree, et al.
Published: (2024-11-01)

BLUR
by: Moysés Pinto Neto
Published: (2023-07-01)

Climate change unveils hidden microbial dangers
by: Haoxuan Yu
Published: (2025-03-01)

Olanzapine-induced Drug Reaction with Eosinophilia and Systemic Symptoms: Case Report and Review of the Literature
by: Katrin Ickrath, et al.
Published: (2025-05-01)

Hyperbaric Oxygen Therapy Ameliorates Olanzapine-Induced Hypolocomotion in a Rat Model
by: Ahmad Altarifi, et al.
Published: (2024-11-01)

A Case-report of Olanzapine-induced Urticaria
by: Muazzez Çiğdem Oba, et al.
Published: (2025-03-01)

Amantadine-induced corneal edema – A reversible cause of visual blurring in Parkinson’s disease
by: Jacky Ganguly, et al.
Published: (2025-01-01)

Restoration of Partial Blurred Image Based on Blur Detection and Classification
by: Dong Yang, et al.
Published: (2016-01-01)

Efficacy of olanzapine as an antiemetic drug for transcatheter arterial chemoembolization for hepatocellular carcinoma
by: Kyoko Oura, et al.
Published: (2025-05-01)

The hidden dangers in routine medical complaints: uncovering patient harm
by: Shaoting Luo, et al.
Published: (2025-07-01)

Vaping danger: A hidden threat among Malaysia’s youth
by: Norsiah Ali, et al.
Published: (2025-01-01)

Water quality: A hidden danger in anthropogenic desert catchments
by: Kerry L. Griffis‐Kyle, et al.
Published: (2014-03-01)

Investigating the effect of zeaxanthin on olanzapine-induced metabolic disorders in rats
by: Anahita Salehsari, et al.
Published: (2024-11-01)

CD19 -targeted CAR T therapy treating hematologic malignancies: hidden danger is the next neighbor to security?
by: Xueshuai Ye, et al.
Published: (2025-03-01)

Improvement of Tardive Dyskinesias with Olanzapine
by: S. Echater, et al.
Published: (2023-01-01)

Olanzapine: The game-changer “antiemetic”
by: Manikandan Dhanushkodi
Published: (2019-01-01)

Tobacco-free nicotine pouches and the youth addiction crisis: The hidden danger
by: Aiman F. Bhatda, et al.
Published: (2024-09-01)

The hidden danger: prolonged exposure to inorganic contaminants and kidney health in adolescents
by: Xiaoran Xue, et al.
Published: (2025-12-01)

Olanzapine-induced hypertriglyceridemia in cancer care: A silent metabolic risk
by: Bilal Kazi, et al.
Published: (2025-03-01)

Blur Feature Extraction Plus Automatic KNN Matting: A Novel Two Stage Blur Region Detection Method for Local Motion Blurred Images
by: Minghua Zhao, et al.
Published: (2019-01-01)

Optic Disc and Optic Cup Segmentation for Glaucoma Detection from Blur Retinal Images Using Improved Mask-RCNN
by: Tahira Nazir, et al.
Published: (2021-01-01)

Managerial Blurring of Employee Goals
by: Gyula J. Nagy, et al.
Published: (2024-12-01)

Case Report: I want more olanzapine: pharmacogenetic insights into a patient's preference for high-dose olanzapine
by: Liam Korošec Hudnik, et al.
Published: (2025-07-01)

A Case of Combined Baclofen and Carisoprodol Withdrawal: The Hidden Dangers of Muscle Relaxants
by: Rachel P. Sarnoff, et al.
Published: (2024-06-01)

Olanzapine enabled rechallenge after lorlatinib‐induced psychosis: A case report
by: Akiyoshi Yokode, et al.
Published: (2025-06-01)

One-Year Course of Olanzapine-Induced Diabetic Ketoacidosis: A Case Report
by: Mohammed Zain Ulabedin Adhoni, et al.
Published: (2021-10-01)

Exploring the effects of probiotics on olanzapine-induced metabolic syndrome through the gut microbiota
by: Syed Mushraf, et al.
Published: (2024-12-01)

Visual loss and blurred optic discs
by: Ana Bárbara Dias Lopes Urzedo, et al.
Published: (2025-06-01)

Blurring or Development: Research in the Borderland of Science
by: Alexander Sergeev, et al.
Published: (2007-12-01)

Space-driven ROS in cells: a hidden danger to astronaut health and food safety
by: Majid Mokhtari, et al.
Published: (2025-08-01)

Brain SPECT imaging in Huntington's disease before and after therapy with olanzapine: case report
by: ETCHEBEHERE ELBA C. S. C., et al.
Published: (1999-01-01)

Drug-drug interaction of paroxetine on olanzapine and initial dosage optimization in patients with major depressive disorder based on population pharmacokinetics
by: Cun Zhang, et al.
Published: (2025-05-01)

Aviation Safety at the Brink: Unveiling the Hidden Dangers of Wind-Shear-Related Aircraft-Missed Approaches
by: Afaq Khattak, et al.
Published: (2025-02-01)

Comparison of Vernier Acuity Measured with Three Different Water-induced Blur Simulation Methods
by: Vivek Suganthan Ramasubramanian, et al.
Published: (2025-07-01)

Blurring Borders: Innate Immunity with Adaptive Features
by: P. Nemeth, et al.
Published: (2007-01-01)

Neural contrast sensitivity is not affected by myopic blur
by: Niklas Domdei, et al.
Published: (2025-08-01)